Healthcare (SH:603313) Xin Lang Cai Jing·2026-01-06 02:39Core Viewpoint - Dream Lily's stock price has shown fluctuations with a recent increase of 2.01%, while the company has reported significant growth in revenue and net profit for the year [1][2]. Group 1: Stock Performance - As of January 6, Dream Lily's stock price reached 9.15 yuan per share, with a market capitalization of 5.221 billion yuan [1]. - The stock has increased by 2.81% year-to-date, but has seen a decline of 1.29% over the last five trading days and 0.87% over the last twenty days [1]. - The trading volume on January 6 was 28.7984 million yuan, with a turnover rate of 0.56% [1]. Group 2: Financial Performance - For the period from January to September 2025, Dream Lily achieved a revenue of 6.756 billion yuan, reflecting a year-on-year growth of 10.29% [2]. - The net profit attributable to shareholders for the same period was 161 million yuan, marking a substantial increase of 205.18% year-on-year [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Dream Lily was 24,100, a decrease of 0.17% from the previous period [2]. - The average number of circulating shares per shareholder increased by 0.17% to 23,651 shares [2]. - The company has distributed a total of 5.46 billion yuan in dividends since its A-share listing, with 28.5293 million yuan distributed over the last three years [3]. Group 4: Institutional Holdings - As of September 30, 2025, major shareholders included Hua'an Ankang Flexible Allocation Mixed A, which held 6.8838 million shares, a decrease of 2.944 million shares from the previous period [3]. - New institutional shareholders include Jiaoyin Theme Preferred Mixed A, holding 2.9665 million shares, and Ping An Research Selected Mixed A, holding 2.5813 million shares [3]. - Notable exits from the top ten shareholders include Xingquan Social Responsibility Mixed and Southern Performance Growth Mixed A [3].